Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04791826 · ClinicalTrials.gov registry record · NA
Electronic Alerts for Heart Failure Prevention in Diabetes
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 1,524
- Enrollment target
NCT04791826 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,524 participants.
The verdict
NCT04791826, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,524 participants
- Enrollment target
Study Summary
Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality. Recent therapeutic advances in pharmacotherapies, such as sodium-glucose cotransporter-2 inhibitors (SGLT2i), have shown to be beneficial in preventing HF among patients with T2DM. However, despite widely available risk prediction and stratification tools and evidence-based practice guidelines, SGLT-2i medications are under-prescribed in the United States. The proposed study is a pragmatic, single-center, randomized trial to test the feasibility and effectiveness of a clinical decision support (CDS) tool to alert providers and improve HF risk stratification in patients with T2DM.
Interventions
- BEHAVIORAL On-screen electronic alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,524 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2024-05-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04791826
The ClinicalTrials.gov registry entry for NCT04791826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,524 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which On-screen electronic alert is the first listed.
NCT04791826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04791826 about?
NCT04791826 is a clinical study titled "Electronic Alerts for Heart Failure Prevention in Diabetes". Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality. Recent therapeutic advances in pharmacotherapies, such as sodium-glucose cotransporter-2 inhibitors (SGLT2i), have shown to be beneficial in preventing HF ...
What is the current status of trial NCT04791826?
This trial is currently completed. It is a NA study. The enrollment target is 1,524 participants. The study started on 2021-03-25. Estimated completion is 2024-05-07.
What interventions are being tested in trial NCT04791826?
The interventions under investigation include: On-screen electronic alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT04791826?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.